WALTHAM, Mass., June 21 /PRNewswire/ -- Confluent Surgical, Inc. continues to win accolades and recognition for pioneering the development of in-situ polymerized biomaterials for numerous surgical applications. On June 15, 2006, Confluent Surgical's CEO, Dr. Amar Sawhney was awarded the New England Regional Ernst & Young Entrepreneur of the Year Award at the Boston Park Plaza Hotel. Dr. Sawhney received this prestigious award for his commitment to enhancing the way surgeons seal tissue and reduce adhesions.
Speaking at the occasion, Dr. Sawhney said, "It is a great honor to be recognized by the Ernst & Young Entrepreneur Of The Year(R) Awards program. While I am very pleased with this recognition, it really highlights the achievements of the team at Confluent. Our first product, the DuraSeal Dural Sealant, is fast becoming the standard of care in Neurosurgery for dural sealing within a year of FDA approval. At Confluent, we foster the spirit of entrepreneurship by allowing employees to think independently and take reasonable risk without having an undue fear of failure. This culture is enabling us to build a deep pipeline for robust growth, thus realizing our vision for leadership in Biosurgery."
"Amar to me is the kind of ideal manager for a start-up venture," said Dan Cole, general partner of Spray Venture Partners, which invested in Confluent. "He is a very experienced clinical executive and quite market-directed."
Dr. Sawhney is a dynamic innovator who is committed to designing products that improve surgical outcome and patients' quality of life. Confluent Surgical's flagship product, DuraSeal Dural Sealant System is the first and only FDA approved cranial sealant that prevents cerebrospinal fluid leaks following cranial surgery. DuraSeal Sealant is approved outside the United States for spine, vascular, and thoracic applications as well. Additionally, Confluent Surgical manufactures and markets SprayGel Adhesion Barrier for the prevention of postoperative adhesions following abdominopelvic surgical procedures.
Each year Ernst & Young, through its Entrepreneur Of The Year(R) Awards program, recognizes great business achievements and business achievers around the world. Now entering its 20th year, Ernst & Young Entrepreneur Of The Year(R) is the world's most prestigious business award for entrepreneurs. Recognized globally, the award honors the most outstanding entrepreneurs who inspire others with their vision, leadership, and achievements.
About Confluent Surgical
Confluent Surgical, Inc. is a privately held company developing products based on its proprietary technology of in-situ polymerized hydrogels and associated delivery systems for the field of biosurgery. Confluent is developing products to address the need for surgical sealing and post-surgical adhesion prevention applications.
About The Ernst & Young Entrepreneur of the Year(R) Awards
The Ernst & Young Entrepreneur Of The Year(R) Awards program was created and is produced by the Global Consulting Services firm Ernst & Young LLP. As the first award of its kind, the Ernst & Young Entrepreneur of the Year recognizes outstanding entrepreneurs who are building and leading dynamic and growing businesses. The program honors entrepreneurs through regional, national and global award programs in over 100 cities spanning 35 countries. Each year, over 3,000 nominations are received around the globe. From those nominations, roughly 350 Entrepreneur of the Year winners are chosen in June by independent panels of judges in 35 regions across the U.S. The regional and national panels of judges include entrepreneurs and prominent leaders from academia, business and the media.
For additional information, visit the Confluent Surgical and DuraSeal Sealant websites at http://www.confluentsurgical.com and http://www.durasealinfo.com or contact Patrick O'Donnell, Director of Global Marketing, at firstname.lastname@example.org.
Confluent Surgical, Inc.